secwatch.observer — SEC 8-K summary
======================================

Issuer:     MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)
CIK:        0001823239
Form:       8-K
Filed at:   2021-09-03T23:59:59+00:00
Accession:  0001823239-21-000023
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 2.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Maravai closes sale of Protein Detection segment; amends Pfizer/BioNTech supply pact
--------------------------------------------------------------------------------

- Closed sale of Vector Laboratories (Protein Detection) to Voyager Group/Thompson Street on Sept 2, 2021.
- Disposition not considered a significant business; Vector CEO Lisa Sellers leaves Maravai.
- Amendment to TriLink supply agreement with Pfizer and BioNTech shifts invoicing to shipment-based from milestone-based.
- Amendment effective June 6, 2021; redacted pricing/billing terms included.
- Deal amendments clarify payments for facility relocation and exclude certain payables from purchase price adjustments.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1823239/000182323921000023/0001823239-21-000023-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1823239/000182323921000023/mrvi-20210902.htm
  HTML page:      https://secwatch.observer/filing/0001823239-21-000023

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer